We are live on
!
Find out more
AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$26.5M
(+9.7%)
Cap. Flow
+$30.1M
Cap. Flow
% of AUM
10.07%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
118
New
6
Increased
104
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lightspeed Commerce
LSPD
|
+$5.25M |
| 2 |
Descartes Systems
DSGX
|
+$3.03M |
| 3 |
Legend Biotech
LEGN
|
+$1.39M |
| 4 |
Bruker
BRKR
|
+$1.25M |
| 5 |
Rocket Lab Corp
RKLB
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$1.31M |
| 2 |
BioNTech
BNTX
|
+$1.14M |
| 3 |
Momentus
MNTS
|
+$928K |
| 4 |
Seres Therapeutics
MCRB
|
+$843K |
| 5 |
Abbott
ABT
|
+$798K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.29% |
| 2 | Healthcare | 31.99% |
| 3 | Financials | 9.06% |
| 4 | Industrials | 6.13% |
| 5 | Consumer Discretionary | 3.45% |
Similar funds
JCI
SC
AOGP
ACJ
UFG
KC
P
AMC
AtonRa Partners's Q3 2021 Portfolio in Review
As of Q3 2021, AtonRa Partners held 118 positions worth $299M, up 9.7% from $273M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AtonRa Partners deployed $30.1M of net new capital in Q3 2021, opening 6 new positions and adding to 104 existing holdings. Its largest new stake was Lightspeed Commerce: 52,877 shares worth $5.1M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 44% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was BioNTech, an estimated $1.14M trimmed.
- AtonRa Partners's largest Q3 2021 buy was Lightspeed Commerce: 52,877 shares worth $5.1M.
- AtonRa Partners added most to Pacific Biosciences in Q3 2021, an estimated $1.08M increase.
- AtonRa Partners's biggest Q3 2021 reduction was BioNTech, cutting an estimated $1.14M.
- AtonRa Partners fully exited Acadia Pharmaceuticals in Q3 2021, selling an estimated $1.31M.
- AtonRa Partners's ten largest holdings make up 22% of its $299M portfolio in Q3 2021.
- AtonRa Partners opened 6 new positions and closed 3 in Q3 2021.
- AtonRa Partners's portfolio value rose 9.7% quarter-over-quarter to $299M.
Based on AtonRa Partners's 13F filing for Q3 2021, filed 15 Nov 2021.